What Fueled The Previous Growth In The Wearable Infusion Pumps Market?
The wearable infusion pumps market has seen considerable growth due to a variety of factors.
• The market size of wearable infusion pumps has experienced significant growth in the past few years. The market is set to expand from $1.37 billion in 2024 to $1.51 billion in 2025, growing at a compound annual growth rate (CAGR) of 9.8%.
The historical growth can be linked to an increase in chronic illnesses, an aging population, an increase in global healthcare expenditures, heightened awareness and education, and advancements in drug formulations.
How Does the Forecast Look for the Wearable Infusion Pumps Market?
The wearable infusion pumps market is expected to maintain its strong growth trajectory in upcoming years.
• The projected growth for the wearable infusion pumps market size appears to be strong for the upcoming years. This market is predicted to reach $2.16 billion by 2029, with a compound annual growth rate (CAGR) of 9.5%.
The escalation in the forecast period can be credited to the increase in chronic diseases, a rising aging population worldwide, a surge in patient inclination towards minimally invasive therapies, and expansion and improvement of healthcare infrastructure in developing markets. Key trends for the forecast period encompass the integration of sophisticated technology, invention of smaller and more discrete devices, customizable infusion parameters, and dosage modifications, and improved data analytics.
What Are The Leading Drivers Of Growth In The Wearable Infusion Pumps Market?
The escalating incidence rate of chronic health conditions is foreseen to stimulate the expansion of the wearable infusion pump market in the near future. Chronic illnesses are long-lasting medical complications that mainly evolve gradually and continue for over a year, frequently necessitating sustained medical care. Cancer, cardiac ailments, diabetes, and arthritis are among the significant chronic diseases. The incidence rate of these chronic illnesses is on the rise, owing to a mixture of genetic, lifestyle, and environmental factors, which includes poor nutrition, inadequate physical activity, and exposure to harmful toxins. Wearable infusion pumps offer substantial aid to those dealing with chronic diseases by ensuring a steady, accurate delivery of the required medications, thereby enhancing treatment compliance and improving the treatment process. For instance, the National Health Service, a public healthcare system based in the UK, reported in June 2024 that 3,615,330 individuals were registered with a GP for non-diabetic hyperglycemia (pre-diabetes) in 2023. This figure marks an increase of 18% from 3,065,825 in 2022, highlighting a significant year-over-year surge in pre-diabetes cases. Consequently, the growing incidence rate of chronic health conditions is predicted to fuel the wearable infusion pump market.
How Are The Segments Defined Within The Global Wearable Infusion Pumps Market?
The wearable infusion pumpsmarket covered in this report is segmented –
1) By Type: Electronic Ambulatory Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps, Large Volume Pumps, Syringe Pumps, Other Types
2) By Usage: Disposable, Reusable
3) By Application: Diabetes, Antibiotic Infusion, Chemotherapy, Pain Management, Parkinson's Disease, Other Applications
Subsegments:
1) Electronic Ambulatory Infusion Pumps: Portable Infusion Pumps, Implantable Infusion Pumps
2) Patient-Controlled Analgesia (PCA) Pumps: Continuous PCA Pumps, Demand PCA Pumps
3) Large Volume Pumps: Volumetric Pumps, Gravity Pumps
4) Syringe Pumps: Infusion Syringe Pumps, Ambulatory Syringe Pumps
5) Other Types: Insulin Pumps, Chemotherapy Pumps
Pre-Book The Wearable Infusion Pumps Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Wearable Infusion Pumps Market?
Leading businesses in the wearable infusion pump marketplace are innovating to create superior products like tube-free, wearable, and single-use insulin pumps that enhance the customer's comfort, reinforce compliance with treatment plans, and make insulin delivery for diabetes management more efficient and discreet. These small devices, which adhere directly to the skin, facilitate round-the-clock insulin administration, removing the need for external tubes, and are substituted after a prescribed duration. In an illustrative example from February 2023, GulfDrug LLC, a healthcare firm based in the UAE, unveiled EOPatch. A breakthrough product, this tube-free, wearable, and disposable insulin pump can be managed from Android and iOS smartphones using the Narsha app. With capabilities such as up to 84 uninterrupted hours of insulin delivery, reducing replacement to biweekly, and the feature to interact with selected blood glucose meters through Bluetooth, this approach is noteworthy. Needed for this purpose, the Narsha app is the inaugural smartphone application that amalgamates insulin delivery management and diabetes data monitoring, thus eliminating the requirement for an individual controller.
Who Are the Key Players In The Wearable Infusion Pumps Market?
Major companies operating in the wearable infusion pumps market are:
• Fresenius SE & Co. KGaA
• Medtronic Plc
• Medline Industries Inc.
• Becton Dickinson and Company
• Baxter International Inc.
• B. Braun Melsungen AG
• Nipro Corporation
• ICU Medical Inc.
• Insulet Corporation
• Sorenson Medical
• Avanos Medical Inc.
• Vygon SA
• pfm medical GmbH
• Eitan Medical
• Micrel Medical Devices SA
• Zyno Medical LLC
• Q-Core Medical Ltd.
• Epic Medical Solutions
• MOOG Inc.
• Smiths Medical International Ltd
What Is The Most Dominant Region In The Wearable Infusion Pumps Market?
North America was the largest region in the wearable infusion pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
